
Two pharmaceutical companies said Tuesday that they have made notable progress with a vaccine that could prevent melanoma. Moderna, well known for its work on the COVID vaccine, and Merck, which makes the cancer immunotherapy drug Keytruda, announced that the combination performed well in a small study of patients who had the cancer surgically removed.… read on > read on >